WallStreetZenWallStreetZen

NASDAQ: JSPR
Jasper Therapeutics Inc Stock Ownership - Who owns Jasper Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Jasper Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jeetinder Singh MahalChief Operating Officer2024-03-12900$26.44
$23.79kSell
Jeetinder Singh MahalChief Operating Officer2024-03-12900$7.10
$6.39kBuy
Carlyle Group IncInsider2024-02-08190,000$12.95
$2.46MBuy
Velan Capital Investment Management LP10% Owner2024-02-08350,000$12.95
$4.53MBuy
Thomas G. WiggansDirector2023-11-2810,000$0.65
$6.49kBuy
Thomas G. WiggansDirector2023-11-2110,000$0.64
$6.38kBuy
Thomas G. WiggansDirector2023-11-2010,000$0.63
$6.31kBuy
Thomas G. WiggansDirector2023-11-1710,000$0.60
$5.97kBuy
Thomas G. WiggansDirector2023-11-1610,000$0.60
$5.97kBuy
William LisDirector2023-10-137,965$0.85
$6.78kSell

1 of 2

JSPR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JSPR insiders and whales buy or sell their stock.

JSPR Shareholders

What type of owners hold Jasper Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Velan Capital Investment Management LP74.48%11,219,036$237.62MInstitution
Soleus Capital Management LP65.53%9,870,980$209.07MInstitution
Roche Holding Ltd60.90%9,174,212$194.31MInsider
Carlyle Group Inc58.16%8,761,891$185.58MInstitution
Qiming Us Ventures Management LLC56.56%8,519,648$180.45MInstitution
Qiming Us Healthcare Fund Ii LP56.56%8,519,648$180.45MInsider
Barney A. Richmond42.91%6,464,048$136.91MInsider
Kurt Von Emster37.51%5,649,733$119.66MInsider
Abingworth LLP37.36%5,628,558$119.21MInsider
Octagon Capital Advisors LP29.66%4,468,114$94.63MInstitution

1 of 3

JSPR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JSPR60.15%39.85%Net BuyingNet Buying
MGTX51.67%48.33%Net Buying
BDTX60.10%39.90%Net BuyingNet Buying
NAUT40.64%59.36%Net BuyingNet Buying
AVIR65.45%25.19%Net SellingNet Selling
View Top Biotech Stocks

Jasper Therapeutics Stock Ownership FAQ

Who owns Jasper Therapeutics?

Jasper Therapeutics (NASDAQ: JSPR) is owned by 501.15% institutional shareholders, 331.96% Jasper Therapeutics insiders, and 0.00% retail investors. Roche Holding Ltd is the largest individual Jasper Therapeutics shareholder, owning 9.17M shares representing 60.90% of the company. Roche Holding Ltd's Jasper Therapeutics shares are currently valued at $187.15M.

If you're new to stock investing, here's how to buy Jasper Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.